Andrew C. Orth - 15 Oct 2026 Form 3 Insider Report for CITY THERAPEUTICS, INC. (CTY)

Reporting relationship: President & CEO, Director
Issuer ticker: CTY
Reported as of: 15 Oct 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 15 Oct 2026, 21:09:27 UTC
Prior SEC filing: 09 Jun 2023
Next SEC filing: 19 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary Beth DeLena, Attorney-in-Fact

Filing notes and source

Key filing fact

Andrew C. Orth filed Form 3 for CITY THERAPEUTICS, INC. (CTY) on 15 Oct 2026.

Key facts

This page summarizes Andrew C. Orth's Form 3 filing for CITY THERAPEUTICS, INC. (CTY).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 15 Oct 2026, 21:09.

Change

Previous filing in this sequence was filed on 09 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001860010 Primary reporting owner

ORTH ANDREW C.

Relationship: President & CEO, Director
Address: 399 BINNEY STREET, CAMBRIDGE
Signature: /s/ Mary Beth DeLena, Attorney-in-Fact
Signature date: 15 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,063,154
Date: 15 Oct 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTY holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 15 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 285,558
Exercise price: $0.9200
Footnotes: F1

CTY holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 15 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 301,358
Exercise price: $5.36
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

25% of the shares underlying this option vested on December 2, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Footnote F2

The shares underlying this option vest in 48 equal monthly installments following June 3, 2026, subject to the Reporting Person's continued service on each such vesting date.

SEC remarks

Exhibit 24 - Power of Attorney